Announcements

Matador CEO to Host the Pistoia Alliance’s Emerging Science & Technology in Japan Life Sciences on 7th July 2022

Once again, the Pistoia Alliance an organisation with a global mission to “lower barriers to innovation in life science R&D & healthcare,” kindly invited Matador CEO, John Bolger to introduce a webinar in its series of Japan Outreach events to provide some specific examples of where its pre-competitive collaboration model of shared-risk and shared-reward can bring value.

Keynote presentations will be given by a distinguished speaker from the Japanese Ministry of Education, Culture, Sports, Science, and Technology Office for Quantum Science and Technology and from Hisafumi Yamada, Executive Vice President, Research and Translational Research, Chugai Pharmaceutical.

John Bolger will perform the master of ceremonies throughout the webinar and will also lead the panel discussion on the subject of the future of pharma R&D / pre-competitive open innovation and the role of emerging science and technology. Panelists will be senior figures from Mitsubishi Tanabe Pharma, Daiichi Sankyo, Preferred Networks, QunaSys and Mr Yamada from Chugai Pharmaceutical,.

https://www.pistoiaalliance.org/eventdetails/global-knowledge-sharing-japan-july-2022/

Partner With Us

Offering overseas technology companies a low-risk, highly rewarding entry strategy to the Japanese pharma market